Clinical Trial Evidence The head-to-head comparison comes from the SURPASS clinical trial program for diabetes and SURMOUNT program for weight loss
I cant say enough about how impressed I am
The common adverse reactions of GLP-1R agonists include gastrointestinal reactions, mainly loss of appetite, nausea, vomiting, diarrhea, abdominal pain, etc., primarily mild or moderate
The following symptoms mean the answer is the ER, not a mobile nurse: Extreme lethargy or unresponsiveness No urination for 8 or more hours Inability to keep any fluid down for 6 or more hours Rapid or labored breathing Sunken eyes, or a sunken fontanelle in infants Cool or mottled skin on the limbs Fainting or near-fainting Blue-tinged lips or fingernails These are ER presentations, not symptoms to monitor at home while waiting for a nurse to arrive
The Ozempic label notes that about 0.2 percent of patients reported injection site reactions in placebo-controlled trials
Spector R, Johanson C